Myovant Sciences Ltd. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 35 rows in 2023. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2023-03-10: Reporting owner Valente Nancy; Form 4; Security Stock Options (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2023-03-10: Reporting owner POTTER MYRTLE S; Form 4; Security Stock Options (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2023-03-10: Reporting owner POTTER MYRTLE S; Form 4; Security Stock Options (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2023-03-10: Reporting owner POTTER MYRTLE S; Form 4; Security Stock Options (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2023-03-10 | Valente Nancy Director | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −36,892 0 owned after | $22.71 exercise price | 2023-03-10 | |
| 2023-03-10 | POTTER MYRTLE S Director | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −45,000 0 owned after | $26.17 exercise price | 2023-03-10 | |
| 2023-03-10 | POTTER MYRTLE S Director | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −58,608 0 owned after | $7.65 exercise price | 2023-03-10 | |
| 2023-03-10 | POTTER MYRTLE S Director | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −21,603 0 owned after | $21.47 exercise price | 2023-03-10 | |
| 2023-03-10 | POTTER MYRTLE S Director | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −21,096 0 owned after | $22.71 exercise price | 2023-03-10 | |
| 2023-03-10 | Merendino Lauren Officer (Chief Commercial Officer) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −123,300 0 owned after | $17.88 exercise price | 2023-03-10 | |
| 2023-03-10 | Mehra Uneek Officer (Principal Financial Officer) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −165,192 0 owned after | $21.83 exercise price | 2023-03-10 | |
| 2023-03-10 | Marek David C Director, Officer (Principal Executive Officer) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −306,427 0 owned after | $20.54 exercise price | 2023-03-10 | |
| 2023-03-10 | Marek David C Director, Officer (Principal Executive Officer) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −208,218 0 owned after | $17.88 exercise price | 2023-03-10 | |
| 2023-03-10 | Marek David C Director, Officer (Principal Executive Officer) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −204,808 0 owned after | $11.33 exercise price | 2023-03-10 | |
| 2023-03-10 | Lang Matthew Officer (General Counsel & Corp. Secy.) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −220,000 0 owned after | $7.78 exercise price | 2023-03-10 | |
| 2023-03-10 | Lang Matthew Officer (General Counsel & Corp. Secy.) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −87,050 0 owned after | $7.78 exercise price | 2023-03-10 | |
| 2023-03-10 | Lang Matthew Officer (General Counsel & Corp. Secy.) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −152,110 0 owned after | $7.78 exercise price | 2023-03-10 | |
| 2023-03-10 | Lang Matthew Officer (General Counsel & Corp. Secy.) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −170,396 0 owned after | $8.08 exercise price | 2023-03-10 | |
| 2023-03-10 | Lang Matthew Officer (General Counsel & Corp. Secy.) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −90,310 0 owned after | $17.88 exercise price | 2023-03-10 | |
| 2023-03-10 | Gulfo Adele M. Director | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −45,000 0 owned after | $11.17 exercise price | 2023-03-10 | |
| 2023-03-10 | Gulfo Adele M. Director | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −21,603 0 owned after | $21.47 exercise price | 2023-03-10 | |
| 2023-03-10 | Gulfo Adele M. Director | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −21,096 0 owned after | $22.71 exercise price | 2023-03-10 | |
| 2023-03-10 | GUINAN MARK Director | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −45,000 0 owned after | $19.71 exercise price | 2023-03-10 | |
| 2023-03-10 | GUINAN MARK Director | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −58,608 0 owned after | $7.65 exercise price | 2023-03-10 | |
| 2023-03-10 | GUINAN MARK Director | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −21,603 0 owned after | $21.47 exercise price | 2023-03-10 | |
| 2023-03-10 | GUINAN MARK Director | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −21,096 0 owned after | $22.71 exercise price | 2023-03-10 | |
| 2023-03-10 | Curran Terrie Director | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −33,846 0 owned after | $11.30 exercise price | 2023-03-10 | |
| 2023-03-10 | Curran Terrie Director | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −11,154 0 owned after | $12.68 exercise price | 2023-03-10 | |
| 2023-03-10 | Curran Terrie Director | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −22,500 0 owned after | $13.14 exercise price | 2023-03-10 | |
| 2023-03-10 | Curran Terrie Director | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −22,500 0 owned after | $24.25 exercise price | 2023-03-10 | |
| 2023-03-10 | Curran Terrie Director | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −5,250 0 owned after | $7.65 exercise price | 2023-03-10 | |
| 2023-03-10 | Curran Terrie Director | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −21,603 0 owned after | $21.47 exercise price | 2023-03-10 | |
| 2023-03-10 | Curran Terrie Director | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −21,096 0 owned after | $22.71 exercise price | 2023-03-10 | |
| 2023-03-10 | Arjona Ferreira Juan Camilo Officer (Chief Medical Officer) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −155,300 0 owned after | $7.78 exercise price | 2023-03-10 | |
| 2023-03-10 | Arjona Ferreira Juan Camilo Officer (Chief Medical Officer) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −63,717 0 owned after | $7.78 exercise price | 2023-03-10 | |
| 2023-03-10 | Arjona Ferreira Juan Camilo Officer (Chief Medical Officer) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −65,863 0 owned after | $7.78 exercise price | 2023-03-10 | |
| 2023-03-10 | Arjona Ferreira Juan Camilo Officer (Chief Medical Officer) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −134,464 0 owned after | $8.08 exercise price | 2023-03-10 | |
| 2023-03-10 | Arjona Ferreira Juan Camilo Officer (Chief Medical Officer) | 4 | Stock Options (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −79,472 0 owned after | $17.88 exercise price | 2023-03-10 | |
| 2023-03-03 | Sumitomo Pharma Co., Ltd. | Sumitovant Biopharma Ltd. | Sumitomo Chemical Co., Ltd. 10% Owner | 10% Owner | 10% Owner | 4 | Option (Right to Acquire) Derivative · Indirect · See Footnote | J Other acquisition or disposition (describe transaction) | +1 1 owned after | $27.00 exercise price | 2023-03-06 |